Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03558282 · ClinicalTrials.gov registry record
Facial Mucosal Level Determinants for Single Immediately Placed Implants Evaluated by Novel Ultrasonography
A clinical trial of Gingival Recession, sponsored by University of Michigan.
- Completed
- Registry status
- 28
- Enrollment target
- 1
- Study location
NCT03558282: Completed study of Gingival Recession, sponsored by University of Michigan.
NCT03558282 is a study of Gingival Recession that has completed, run by University of Michigan. The registered enrollment target is 28 participants, below the 31-participant average among 10 other Gingival Recession trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03558282, a study of Gingival Recession, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
A single center, prospective clinical trial is planned to investigate the effect of different emergence angles of implant restorations on peri-implant soft tissue recession and implant marginal bone loss. The primary outcome is to systematically evaluate the association of implant-, peri-implant tissue-, and restoration-related factors with facial mucosal level changes.
Primary Outcome
It is a one-time measurement (this study is only one-time visit) within the study timeframe, measured from a reference, adjacent tooth landmark, to the mucosal margin of the implant.
Conditions Studied
Interventions
- OTHER Recession Observation
- DIAGNOSTIC_TEST Crown Contour Observation
Study Locations (1)
Michigan
- University of Michigan School of Dentistry - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2018-08-07 |
| Est. Completion | 2019-01-22 |
What the finished NCT03558282 record still lists
NCT03558282 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 31-participant average among 10 other Gingival Recession trials with a reported enrollment target (10% lower).
The record links to 1 condition, with Gingival Recession appearing as the primary indexed condition, and to 2 interventions - of which Recession Observation is the first listed.
NCT03558282 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03558282 about?
NCT03558282 is a clinical study titled "Facial Mucosal Level Determinants for Single Immediately Placed Implants Evaluated by Novel Ultrasonography". A single center, prospective clinical trial is planned to investigate the effect of different emergence angles of implant restorations on peri-implant soft tissue recession and implant marginal bone loss. The primary outcome is to systematically evaluate the association of implant-, peri-implant ti...
What is the current status of trial NCT03558282?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2018-08-07. Estimated completion is 2019-01-22.
What conditions does trial NCT03558282 study?
This clinical trial studies the following conditions: Gingival Recession.
What interventions are being tested in trial NCT03558282?
The interventions under investigation include: Recession Observation (OTHER), Crown Contour Observation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03558282?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03558282 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingival Recession
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03558282's enrollment target sits among peer trials
28 7th of 10 higher than 4 of 10 other Gingival Recession trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gingival Recession trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gain of Keratinized Mucosa Around Teeth and Dental Implants Using a Combination of Strip Gingival Graft and Acellular Dermal Matrix
RECRUITING · NA
-
Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
RECRUITING · NA
-
Changes of Soft Tissue Grafting: A Randomized Study
RECRUITING · NA
-
A Clinical Trial Testing Root Coverage With Acellular Dermal Matrix in Thin and Thick Gingival Biotypes
ACTIVE NOT RECRUITING · Phase 4
-
A Comparison of Side Access Mucosal Releasing Incision (SAMRI) and Sulcular Tunnel Access to Treat Gingival Recession.
ACTIVE NOT RECRUITING · NA
-
Thick vs. Thin Acellular Dermal Matrix (ADM)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI